CYTK: MYQORZO's strong launch and ACACIA-HCM data drive optimism for expanded HCM market leadership
ACACIA-HCM data positions MYQORZO for expanded HCM approval, with strong commercial momentum and rapid new-to-brand share growth. The NHCM market is now seen as a major opportunity, and preparations are underway for broader launches and increased SG&A. Omecamtiv mecarbil's COMET-HF trial could deli…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.